Cidara Therapeutics (CDTX) Tops Q3 EPS by 21c

Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($0.73), $0.21 better than the analyst estimate of ($0.94).

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• The LGL Group (LGL) Misses Q2 EPS by 8c